Inventor · disambiguated record
Franck Raeppel
Also filed as: RAEPPEL FRANCK
13 granted patents·7 pending applications·20 citations·filing 2005–2020
87Inventor score
Files withMETHYLGENE INC10SAAVEDRA OSCAR MARIO2ADURO BIOTECH INC1ELKIMIA INC1MIRATI THERAPEUTICS INC1
Top patents by PatentIndex Score
20 records- 0182US8907091B2Processes and intermediates for preparing fused heterocyclic kinase inhibitorsRAEPPEL FRANCK·Filed 2008·Granted Dec 9, 2014·7 cites·4 claims
- 0278US8455484B2Selected inhibitors of protein tyrosine kinase activityRAEPPEL STEPHANE·Filed 2011·Granted Jun 4, 2013·5 cites·15 claims
- 0378US7790729B2Inhibitors of VEGF receptor and HGF receptor signalingMETHYLGENE INC·Filed 2006·Granted Sep 7, 2010·1 cites·55 claims
- 0476US9018378B2Processes and intermediates for preparing fused heterocyclic kinase inhibitorsMETHYLGENE INC·Filed 2013·Granted Apr 28, 2015·1 cites·6 claims
- 0573US9636298B2Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugsMETHYLGENE INC·Filed 2015·Granted May 2, 2017·1 cites·7 claims
- 0672US8093264B2Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signalingSAAVEDRA OSCAR MARIO·Filed 2006·Granted Jan 10, 2012·2 cites·25 claims
- 0771US7772247B2Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptorMETHYLGENE INC·Filed 2005·Granted Aug 10, 2010·1 cites·77 claims
- 0867US8470850B2Inhibitors of VEGF receptor and HGF receptor signallingVAISBURG ARKADII·Filed 2010·Granted Jun 25, 2013·2 cites·46 claims
- 0957US12466838B2Crystalline form of a multi-tyrosine kinase inhibitor, method of preparation, and use thereofMIRATI THERAPEUTICS INC·Filed 2020·Granted Nov 11, 2025·0 cites·31 claims
- 1056US2014315801A1Methods of treatment of cell proliferative and/or ophthalmic diseases, disorders and conditions using inhibitors of protein tyrosine kinase activityMETHYLGENE INC·Filed 2014·Application pending·0 cites
- 1147US2008064718A1Inhibitors of protein tyrosine kinase activitySAAVEDRA OSCAR M·Filed 2007·Application pending·0 cites
- 1246US2013096135A1Selected Inhibitors of Protein Tyrosine Kinase ActivityMETHYLGENE INC·Filed 2012·Application pending·0 cites
- 1344US2014081017A1Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal AgentsMETHYLGENE INC·Filed 2013·Application pending·0 cites
- 1443US8906852B2Inhibitors of protein tyrosine kinase activityRAEPPEL STÉPHANE·Filed 2011·Granted Dec 9, 2014·0 cites·17 claims
- 1541US8329726B2Inhibitors of VEGF receptor and HGF receptor signalingSAAVEDRA OSCAR MARIO·Filed 2011·Granted Dec 11, 2012·0 cites·13 claims
- 1641US2010249145A1Inhibitors of VEGF Receptor and HGF Receptor SignalingMETHYLGENE INC·Filed 2010·Application pending·0 cites
- 1740US2013096088A1Inhibitors of Protein Tyrosine Kinase ActivityMETHYLGENE INC·Filed 2012·Application pending·0 cites
- 1840US2013090327A1Inhibitors of Protein Tyrosine Kinase ActivityMETHYLGENE INC·Filed 2012·Application pending·0 cites
- 1937US9487474B2Imino compounds as protecting agents against ultraviolet radiationsELKIMIA INC·Filed 2013·Granted Nov 8, 2016·0 cites·17 claims
- 2035US10738056B2Pyrazolopyrimidinone compounds and uses thereofADURO BIOTECH INC·Filed 2018·Granted Aug 11, 2020·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Franck Raeppel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →